SAN FRANCISCO — Medtronic and Edwards Lifesciences have reached a global settlement of their patent litigation, wiping out two large jury awards that had raised the threat of an injunction against potentially life-saving heart valve technology.
Medtronic Inc., which had been hit with infringement verdicts of $74 million in 2010 and $394 million in January of this year, agreed to pay Edwards $750 million up front and royalties of at least $40 million a year for the next eight years.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
